SYNRIBO for Injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with SYNRIBO.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of SYNRIBO (omacetaxine mepesuccinate) for Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the SYNRIBO (omacetaxine mepesuccinate) for Injection medicine cost price in India.
The order for SYNRIBO (omacetaxine mepesuccinate) for Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Omacetaxine mepesuccinate is a cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia. It has a role as an antineoplastic agent, a protein synthesis inhibitor and an apoptosis inducer.
SYNRIBO™ (omacetaxine mepesuccinate) for Injection, for subcutaneous use Initial U.S. Approval: 2012
Generic Name: omacetaxine mepesuccinate
Single-use vial containing 3.5 mg of omacetaxine mepesuccinate as a lyophilized powder. .
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand SYNRIBO (omacetaxine mepesuccinate) for Injection on prescription and Import License in Patient's Name only.
For overseas patients, SYNRIBO (omacetaxine mepesuccinate) for Injection can be made available in Send your enquiry to find SYNRIBO (omacetaxine mepesuccinate) for Injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For SYNRIBO (omacetaxine mepesuccinate) for Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
FDA Approves Omacetaxine (Synribo) for CML For More Details
Teva Receives FDA Approval For Leukemia Treatment For Injection For More Details